Literature DB >> 2848203

Facilitatory presynaptic angiotensin receptors on the sympathetic nerves of the human saphenous vein and pulmonary artery. Potential involvement in beta-adrenoceptor-mediated facilitation of noradrenaline release.

G J Molderings1, J Likungu, F Hentrich, M Göthert.   

Abstract

Spirally cut strips of human saphenous vein and pulmonary artery preincubated with 3H-noradrenaline were superfused in the presence of corticosterone and desipramine or cocaine. In the saphenous vein angiotensin I, angiotensin II and angiotensin III concentration-dependently increased the electrically (2 Hz) evoked tritium overflow (relative order of potency: angiotensin II greater than angiotensin I greater than angiotensin III). The angiotensin receptor antagonist saralasin displaced the concentration-response curve of angiotensin II to the right, and also blocked the facilitatory effect of angiotensin III. Captopril, an inhibitor of angiotensin converting enzyme, did not modify the concentration-response curve of angiotensin I and did not significantly diminish the release-increasing effect of the nonselective beta-adrenoceptor agonist isoprenaline, whereas saralasin attenuated the facilitatory effect of the beta 2-adrenoceptor agonist procaterol. In the pulmonary artery the angiotensin receptor agonist Val5-angiotensin II-Asp1-beta-amide also increased the electrically evoked tritium overflow in a concentration-dependent manner. It is concluded that the sympathetic nerve fibres of the human saphenous vein (and probably of the human pulmonary artery as well) are endowed with facilitatory presynaptic angiotensin receptors. Angiotensin I exerted its facilitatory effect in the saphenous vein probably via direct stimulation of angiotensin receptors but not by conversion to angiotensin II. Furthermore, the beta 2-adrenoceptor-induced facilitation of noradrenaline release may in part be mediated by local stimulation of angiotensin II synthesis, which may occur by increased formation or activation of renin and/or increased availability of angiotensinogen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848203     DOI: 10.1007/bf00173392

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

1.  Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function.

Authors:  V J Dzau
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

2.  Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat.

Authors:  T Unger; B Schüll; W Rascher; R E Lang; D Ganten
Journal:  Biochem Pharmacol       Date:  1982-10-01       Impact factor: 5.858

3.  Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries.

Authors:  K U Malik; A Nasjletti
Journal:  Circ Res       Date:  1976-01       Impact factor: 17.367

4.  Subendothelial beta 2-adrenoceptors in the rat vena cava: facilitation of noradrenaline release via local stimulation of angiotensin II synthesis.

Authors:  M Göthert; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

5.  Beta-adrenoceptor-mediated release of angiotensin II from mesenteric arteries.

Authors:  M Nakamaru; E K Jackson; T Inagami
Journal:  Am J Physiol       Date:  1986-01

6.  Prejunctional inhibition of norepinephrine release caused by acetylcholine in the human saphenous vein.

Authors:  D K Rorie; N J Rusch; J T Shepherd; P M Vanhoutte; G M Tyce
Journal:  Circ Res       Date:  1981-08       Impact factor: 17.367

7.  Arterial wall renin and renal venous renin in the hypertensive rat.

Authors:  J B Garst; S Koletsky; P E Wisenbaugh; M Hadady; D Matthews
Journal:  Clin Sci (Lond)       Date:  1979-01       Impact factor: 6.124

8.  Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery.

Authors:  T Endo; K Starke; A Bangerter; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-02       Impact factor: 3.000

Review 9.  Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors.

Authors:  H Majewski
Journal:  J Auton Pharmacol       Date:  1983-03

Review 10.  Presynaptic beta-adrenoceptors.

Authors:  Y Misu; T Kubo
Journal:  Med Res Rev       Date:  1986 Apr-Jun       Impact factor: 12.944

View more
  3 in total

1.  Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues.

Authors:  S L Cox; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype.

Authors:  G J Molderings; K Werner; J Likungu; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

3.  Role of angiotensin and sodium intake in cardiac noradrenaline release.

Authors:  G Richardt; E Mayer; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.